Lyophilized thioxanthenone antitumor agents
US5665760A · kind A · utility
3Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 1995 |
| Grant date | Sep 9, 1997 |
| Priority date | — |
| Expiry date | Sep 18, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are reconstituted lyophilized formulations for the treatment of mammalian tumors comprising a thioxanthenone antitumor agent in combination with mannitol or sucrose as a stabilizer in a lactate buffer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.